KFF COVID-19 Vaccine Monitor: February 2021
Computer-assisted telephone interviews conducted by landline and cell phone were carried out in English and Spanish by SSRS
The KFF COVID-19 Vaccine Monitor is an ongoing research project tracking the public’s attitudes and experiences with COVID-19 vaccinations. Using a combination of surveys and qualitative research, this project tracks the dynamic nature of public opinion as vaccine development and distribution unfold, including vaccine confidence and acceptance, information needs, trusted messengers and messages, as well as the public’s experiences with vaccination.
- As COVID-19 vaccination distribution efforts continue across the United States, the latest KFF COVID-19 Vaccine Monitor reports that a majority (55%) of U.S. adults now say they have received at least one dose of the vaccine (18%) or that they will get it as soon as they can (37%), up from 47% in January and 34% in December. The share that wants to “wait and see” how the vaccine is working for others before getting vaccinated themselves decreased from 31% in January to 22% in February, while a persistent one in five say they will get the vaccine “only if required for work, school, or other activities” (7%) or will “definitely not” get vaccinated (15%).